Abstract:Objective To investigate the levels of serum cathepsin K(Cathe K) in osteoporosis diagnosis. Methods Bone mineral densities of lumbar spine and femoral neck were measured by dual energy X-ray. According to bone mineral densities,187 objects were classified into 63 cases of bone loss and 124 cases of osteoporosis. In osteoporosis group,32 cases' drug treatment efficacy was monitored. A total of 142 healthy subjects were enrolled as healthy control group. Enzyme-linked immunosorbent assay was used to determine serum Cathe K and tartrate-resistant acid phosphatase(TRAP)levels. The levels of osteocalcin(N-MID),beta-collagen degradation product(β-crosslaps) and type Ⅰ procollagen N-terminal propeptide(PⅠNP)were determined by electrochemiluminescence immunoassay. According to ages,objects were classified into 35-45,46-55,56-65, 66-70 and ≥71-year-old groups. Results For 35-45,46-55 and 56-65-year-old groups,the levels of serum Cathe K in osteoporosis group were higher than those in healthy control group(P<0.01),but there was no statistical significance for 66-70 and ≥71-year-old groups between osteoporosis and healthy control groups (P>0.05). For 35-45-year-old group,the level of serum Cathe K in bone loss group was higher than that in healthy control group(P<0.01),and there was no statistical significance for the other age groups(P>0.05). In the analysis of bone turnover markers for 45-65-year-old groups,the levels of serum Cathe K,PⅠNP,β-crosslaps,N-MID and TRAP in osteoporosis group were higher than those in bone loss and healthy control groups(P<0.05). There was no statistical significance between bone loss and healthy control groups(P>0.05). Serum β-crosslaps and Cathe K decreased in osteoporosis group after treatment for 3 months(P<0.05). Conclusions Serum Cathe K can be used in the diagnosis and treatment monitoring of osteoporosis.

Differential Levels of Cathepsin B and L in Serum Between Young and Aged Healthy People and Their Association with Matrix Metalloproteinase 2.

Serum Levels of Cathepsin D, Sirtuin1, and Endothelial Nitric Oxide Synthase Are Correlatively Reduced in Elderly Healthy People

[Age-Related Changes Serum Levels of MMP-1 and MMP-2 in Women: Their Relationship with Bone Biochemical Markers and Bone Mineral Density].

Serum Concentrations of MMP-1, MMP-2, and TIMP-1 in Chinese Women: Age-Related Changes, and the Relationships with Bone Biochemical Markers, Bone Mineral Density.

Association of cathepsin B and cystatin C with an age-related pulmonary subclinical state in a healthy Chinese population

Plasma Cathepsin L Level is Positively Associated with Arterial Stiffness in Geriatric Patients

Elevated circulating procathepsin L as a potential biomarker of inflamm-aging

ELISA for aging biomarkers induced by telomere dysfunction in human plasma.

Association of cathepsin L with coronary heart disease and its risk factors

[Relationships Between Circulating Matrix Metalloproteinase-1, -2 and Metalloproteinase-1 Levels and Bone Biochemical Markers and Bone Mineral Density in Chinese Postmenopausal Women].

Usefulness of serum cathepsin L as an independent biomarker in patients with coronary heart disease.

Increased Circulating Cathepsin L in Patients with Coronary Artery Disease.

Cathepsin in Alzheimer's Disease, Parkinson's Disease and Dementia with Lewy Bodies: Mendelian Randomization Study

Abstract P158: Increased Circulating Cathepsin K in Patients with Chronic Heart Failure

Independent association between serum C-peptide levels and fat mass-to-lean mass ratio in the aging process.

Increased Circulating Cathepsin K in Patients with Chronic Heart Failure

Cathepsin L Expression and Regulation in Human Abdominal Aortic Aneurysm, Atherosclerosis, and Vascular Cells

Decreased serum level of HMGB1 and MyD88 during human aging progress in healthy individuals

Elevated circulating cathepsin S levels are associated with metabolic syndrome in overweight and obese individuals.

Increased expression of mature cathepsin B in aging rat liver

Serum cathepsin K in osteoporosis diagnosis